Alendronic Acid contains alendronic acid (also known as alendronate sodium), a bisphosphonate medicine used to treat and prevent osteoporosis and other conditions associated with bone loss. Osteoporosis weakens bones by reducing bone density and increasing fracture risk, particularly in the spine, hip, and wrist. Alendronic acid works by slowing bone breakdown, helping maintain bone strength and reducing the risk of fractures. Alendronic Acid may be prescribed alone or alongside calcium and vitamin D supplementation, especially in postmenopausal women, older adults, and patients receiving long-term steroid therapy.

Alendronic Acid contains alendronic acid, a bisphosphonate that reduces bone resorption and helps preserve bone mineral density. It is commonly prescribed for postmenopausal osteoporosis, osteoporosis in men, and glucocorticoid-induced osteoporosis, as well as for certain bone disorders such as Paget’s disease of bone.

Bone is constantly renewed through a process involving bone breakdown (resorption) and new bone formation. In osteoporosis, bone breakdown occurs faster than bone formation, leading to fragile bones that fracture more easily. Alendronic acid binds strongly to bone surfaces and inhibits osteoclast activity, the cells responsible for bone resorption. This slows bone loss and allows bone-forming cells to restore strength over time.

Regular treatment with Alendronic Acid has been shown to improve bone density and significantly reduce the risk of vertebral, hip, and other fractures. Because the medicine works directly on bone tissue and remains there for a long time, weekly dosing is often sufficient for many patients.

To maximise absorption and minimise irritation of the oesophagus, alendronic acid must be taken on an empty stomach with plain water and patients should remain upright for at least 30 minutes afterwards. The medicine usually requires long-term use, and benefits become more apparent over several months of consistent treatment.

Alendronic acid is not metabolised extensively and is excreted unchanged by the kidneys, so patients with severe kidney impairment may need alternative therapy. When used correctly under medical supervision, Alendronic Acid is an effective long-term treatment for improving bone strength and reducing fracture risk.

Osteoporosis in Postmenopausal Women

Treatment and prevention of bone loss after menopause to reduce fracture risk.

Osteoporosis in Men

Helps improve bone density and reduce fracture risk in men with osteoporosis.

Glucocorticoid-Induced Osteoporosis

Used in patients taking long-term corticosteroids that weaken bones.

Paget’s Disease of Bone

Helps regulate abnormal bone turnover and improve bone structure.

• Reduces Bone Loss: Slows osteoclast-mediated bone breakdown and preserves bone mass.

• Improves Bone Density: Increases mineral density in the spine, hip, and other weight-bearing bones.

• Fracture Prevention: Significantly lowers the risk of vertebral and hip fractures in high-risk patients.

• Long-Acting Action: Weekly dosing improves adherence and convenience.

• Supports Long-Term Bone Health: Helps maintain skeletal strength during ageing and chronic illness.

• Useful in Steroid Users: Protects bones in patients on long-term corticosteroid treatment.

When taken as directed, Alendronic Acid is generally effective and well tolerated. Side effects are often mild and improve with correct administration.

Common Side Effects:

• Stomach Pain or Indigestion: Mild upper abdominal discomfort may occur.

• Acid Reflux or Heartburn: Irritation of the oesophagus can occur if dosing instructions are not followed.

• Constipation or Diarrhoea: Mild digestive changes are sometimes reported.

• Bone, Muscle, or Joint Pain: Temporary musculoskeletal discomfort may occur.

Uncommon Side Effects:

• Difficulty Swallowing: Oesophageal irritation or inflammation may develop.

• Headache: Occasionally reported during early treatment.

• Nausea: Mild stomach upset may occur.

Serious Side Effects (Require Immediate Medical Attention):

• Severe Chest Pain or Swallowing Pain: May indicate oesophageal ulceration.

• Jaw Pain or Dental Problems: Rare risk of osteonecrosis of the jaw, especially after dental procedures.

• Severe Bone Pain: Persistent or unusual pain requires medical review.

• Eye Inflammation: Redness or pain in the eyes may rarely occur.

Alendronic Acid should be taken exactly as prescribed by your physician. The standard dose is usually one tablet once weekly, taken on the same day each week. Take the tablet first thing in the morning on an empty stomach with a full glass of plain water. Swallow it whole and remain upright (sitting or standing) for at least 30 minutes afterwards. Do not eat, drink, or take other medicines during this period.

The mechanism of Alendronic Acid is based on its ability to inhibit osteoclast-mediated bone resorption. Alendronic acid belongs to the bisphosphonate class and binds strongly to hydroxyapatite crystals in bone.

When osteoclasts attempt to break down bone containing alendronic acid, their activity is reduced and they eventually undergo apoptosis (programmed cell death). This decreases bone turnover and allows osteoblasts (bone-forming cells) to build stronger bone over time.

By reducing excessive bone resorption, alendronic acid improves bone mineral density and lowers fracture risk, particularly in areas prone to osteoporotic fractures such as the hip and spine.

• Correct Administration Is Essential: Take only with plain water and remain upright for 30 minutes.

• Do Not Lie Down After Taking It: This reduces oesophageal irritation risk.

• Maintain Calcium Intake: Calcium and vitamin D improve treatment benefit.

• Dental Care Matters: Inform your dentist if taking alendronic acid long term.

• Monitor Bone Health: Bone density scans may be advised periodically.

• Long-Term Review: Treatment duration should be reviewed regularly.

While Alendronic Acid must be taken on an empty stomach, certain foods and supplements strongly affect absorption.

• Calcium-Rich Foods (High): Milk and calcium supplements reduce absorption if taken too soon after dosing.

• Tea/Coffee (High): Reduce absorption when taken together.

• Mineral Supplements (High): Iron, magnesium, and antacids interfere with absorption.

• Alcohol (Moderate): May worsen gastric irritation and bone loss.

• High-Fibre Meals (Moderate): Delay absorption if taken too soon after the tablet.

Alendronic Acid can interact with medicines that affect absorption or bone metabolism.

• Calcium Supplements (High): Reduce absorption if taken too soon.

• Antacids (High): Interfere with absorption; separate dosing by at least 30 minutes.

• NSAIDs (Moderate): Ibuprofen or similar medicines may increase stomach irritation.

• Corticosteroids (Moderate): Increase fracture risk but often used together with monitoring.

• Vitamin D Supplements (Low-Moderate): Commonly prescribed together for bone support.

Alendronic Acid should be used carefully in patients with certain conditions.

• Oesophageal Disorders (High): Conditions such as strictures or swallowing difficulty increase irritation risk.

• Hypocalcaemia (High): Low calcium levels must be corrected before treatment.

• Severe Kidney Disease (High): Reduced excretion may increase drug accumulation.

• Gastric Ulcer Disease (Moderate): May worsen upper GI symptoms.

• Dental Disease (Moderate): Rare jaw complications require caution.

If you miss your weekly dose, take it the next morning after you remember. Then return to your usual weekly schedule. Do not take two tablets on the same day. Missing occasional doses may reduce long-term benefit, so regular adherence is important.